3D cell migration assay platform for cancer drug screening and validation
Improved success rate of cancer drug discovery
Tests cancer drugs on its deadliest aspect— spreading
Saves millions of animal lives in pre-clinical trials
Saves millions of Euros invested in failed drugs
Our proprietary organ-like hydrogel engineered to recreate human-relevant physiological conditions and preserve tumour heterogeneity as observed in human cancers.
OncoTrix™ is a first-in-class platform that uses structured conditions to reveal functional adaptive behaviours of cancer cells missed by existing systems.
Live behavioural scoring that converts adaptive behaviour into actionable measures of cancer aggressiveness, drug efficacy pharmacodynamics, resistance/relapse risk, and combination performance.
Cymoplive visits India, meets Indian Pharmaceuticals and cancer hospitals
Industrial networking at TERMIS 2023 Manchester, UK
Our first MarGel centric Jule Board! Merry Christmas